Aberdare Ventures
Investment Details
Investor Type
Venture Capital
Asset Class Focus
Private Equity, Venture Capital
Stage Focus
Seed, Early Stage, Series A, Series B, Growth, Late Stage, Pre-IPO
Geographical Focus
United States
Industries Focus
- Healthcare
- Healthcare Services
- Digital Health
- Pharmaceuticals
- Medical Devices
- Diagnostics
- Medtech
- Biotechnology
- Health and Wellness
- Healthcare Technology
- Health Services
- Medical Research
- Medical Equipment
- Health Insurance
- Healthcare IT
- Biopharmaceuticals
- Healthcare Consulting
- Healthcare Research
- Health IT
- Medical Services
Investment Size:
1,000,000 to 50,000,000 USD
Investor Details Founded: 1999
Aberdare Ventures is a prominent venture capital firm based in San Francisco, California, specializing in investments within the healthcare sector. The firm focuses on companies that are transforming healthcare through innovative solutions, aiming to improve efficiency, reduce costs, and enhance the quality of care. Their portfolio includes a diverse range of healthcare companies, from biotechnology and medical devices to healthcare IT and services.
The firm's investment strategy encompasses various stages of company development, including seed, early-stage, and growth investments. Aberdare Ventures is known for its active involvement in portfolio companies, providing strategic guidance and leveraging its extensive network to support growth and operational excellence. The firm seeks to partner with visionary entrepreneurs who are committed to making a significant impact in the healthcare industry.
With a track record of successful investments, Aberdare Ventures has established itself as a key player in the healthcare venture capital landscape. The firm's commitment to innovation and its deep understanding of the healthcare market enable it to identify and nurture companies that are poised to lead in their respective fields. Aberdare Ventures continues to seek out transformative healthcare opportunities that align with its mission to drive positive change in the industry.
Requirements
- Innovative healthcare solutions
- Early-stage companies
- Strong management teams
- Scalable business models
- Potential for significant impact in the healthcare sector
Contact
[Official Website Hidden]
[LinkedIn Profile Hidden]
[HQ Location Hidden]
[Email Hidden]
[Contact Number Hidden]
Portfolio Companies
- Omada Health
- Cricket Health
- Viracta Therapeutics
- GRAVIE
- Mevion Medical Systems
- Clovis Oncology
- MC10
- Wello
- 3-V Biosciences
- Theranos
- Guardant Health
- Thermo Fisher Scientific
- Illumina
- Medtronic
- Boston Scientific
- AbbVie
- Amgen
- Gilead Sciences
- Genentech
- Pfizer
- Merck & Co.
- Johnson & Johnson
- Eli Lilly and Company
- Bristol-Myers Squibb
- Novartis
- AstraZeneca
- Sanofi
- GlaxoSmithKline
- Roche
Mentioned In
-
$24.95
-
$24.95
-
$19.95
-
$49.95
-
$14.95
-
$39.95
-
$99.00
-
$299.00
Claim this Investor
Are you an official representative of Aberdare Ventures?
Claim this investor to update information, manage your profile, and get a verified seal.
Claim